[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f1fuuI9WnzSZbX6qtdrSwGtkiQQoVk8KQYnBkKQxrB20":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":74,"rows":81},"Shaare Zedek Medical Center",[4],193,false,16,19,42689,10,119,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Patent Ductus Arteriosus",7,{"name":18,"count":19},"Cerebral Palsy",6,{"name":21,"count":22},"Pregnancy",4,{"name":24,"count":22},"Crohn's Disease",{"name":26,"count":22},"Inflammatory Bowel Diseases",{"name":28,"count":22},"Gaucher Disease, Type 1",{"name":30,"count":22},"ADHD",{"name":32,"count":22},"Infertility",[34,39,44,49,54,59,64,69],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT03591276","Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer","2021-04-15","Chemotherapy Drugs, Cancer",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06298188","Risankizumab in Children With Crohn's Disease (RisaKids)","2026-10","Risankizumab",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT06870266","Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone","2027-03","Nafarelin nasal spray",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT07604025","Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children: a Randomized, Double-blinded, Study","2027-07-01","PEG 3350",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT07537400","Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5","2028-06","Naxitamab",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT05599360","Vyxeos for Induction of Low- or Intermediate-risk.","2028-09-07","Vyxeos",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT07560462","Budesonide Following Endoscopic Dilatation of Esophageal Strictures in Children.","2029-05-01","Budesonide intervention",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT06785844","Intra-rectal Botulinum Toxin Injection for Intractable Non-retentive Fecal Incontinence in Children - an Open Label Pilot Study","2030-09","Botulinum Toxin A",[75,76,77,78,79,80],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[82,107,129,152,170,191,213,237,255,276,297,334,368,403,429,447,474,499,525,543,568,593,618,645,672,695,748,790,815,841,859,884,902,928,946,970,993,1016,1034,1058,1084,1113,1131,1149,1167,1185,1203,1230,1257,1281,1305,1331,1349,1373,1391,1416,1439,1461,1485,1510,1528,1546,1584,1613,1641,1659,1677,1700,1718,1736,1762,1785,1803,1831,1854,1872,1896,1921,1939,1957,1983,2006,2033,2051,2074,2092,2114,2138,2160,2186,2213,2231,2255,2273],{"intervention":38,"totalTrials":83,"cells":84},1,{"EARLY_PHASE1":85,"PHASE1":88,"PHASE2":90,"PHASE3":101,"PHASE4":103,"NA":105},{"trials":86,"activeCount":87},[],0,{"trials":89,"activeCount":87},[],{"trials":91,"activeCount":83,"soonestReadout":37},[92],{"nctId":35,"briefTitle":36,"status":93,"phases":94,"primaryCompletion":37,"completion":95,"start":96,"enrollment":97,"conditions":98,"interventions":100},"RECRUITING",[76,77],"2021-06-15","2019-04-18",15,[99],"Metastatic Breast Cancer",[38],{"trials":102,"activeCount":87},[],{"trials":104,"activeCount":87},[],{"trials":106,"activeCount":87},[],{"intervention":58,"totalTrials":83,"cells":108},{"EARLY_PHASE1":109,"PHASE1":111,"PHASE2":113,"PHASE3":123,"PHASE4":125,"NA":127},{"trials":110,"activeCount":87},[],{"trials":112,"activeCount":87},[],{"trials":114,"activeCount":83,"soonestReadout":57},[115],{"nctId":55,"briefTitle":56,"status":116,"phases":117,"primaryCompletion":57,"completion":118,"start":119,"enrollment":11,"conditions":120,"interventions":122},"NOT_YET_RECRUITING",[77],"2032-04","2026-05",[121],"High-Risk Neuroblastoma",[58],{"trials":124,"activeCount":87},[],{"trials":126,"activeCount":87},[],{"trials":128,"activeCount":87},[],{"intervention":63,"totalTrials":83,"cells":130},{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":146,"PHASE4":148,"NA":150},{"trials":132,"activeCount":87},[],{"trials":134,"activeCount":87},[],{"trials":136,"activeCount":83,"soonestReadout":62},[137],{"nctId":60,"briefTitle":61,"status":138,"phases":139,"primaryCompletion":62,"completion":62,"start":140,"enrollment":141,"conditions":142,"interventions":144},"ACTIVE_NOT_RECRUITING",[77],"2022-08-07",20,[143],"Leukemia, Myeloid, Acute",[63,145],"Mylotarg",{"trials":147,"activeCount":87},[],{"trials":149,"activeCount":87},[],{"trials":151,"activeCount":87},[],{"intervention":145,"totalTrials":83,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":164,"PHASE4":166,"NA":168},{"trials":155,"activeCount":87},[],{"trials":157,"activeCount":87},[],{"trials":159,"activeCount":83,"soonestReadout":62},[160],{"nctId":60,"briefTitle":61,"status":138,"phases":161,"primaryCompletion":62,"completion":62,"start":140,"enrollment":141,"conditions":162,"interventions":163},[77],[143],[63,145],{"trials":165,"activeCount":87},[],{"trials":167,"activeCount":87},[],{"trials":169,"activeCount":87},[],{"intervention":73,"totalTrials":83,"cells":171},{"EARLY_PHASE1":172,"PHASE1":181,"PHASE2":183,"PHASE3":185,"PHASE4":187,"NA":189},{"trials":173,"activeCount":83,"soonestReadout":72},[174],{"nctId":70,"briefTitle":71,"status":116,"phases":175,"primaryCompletion":72,"completion":72,"start":176,"enrollment":177,"conditions":178,"interventions":180},[75],"2025-02-01",14,[179],"Fecal Incontinence",[73],{"trials":182,"activeCount":87},[],{"trials":184,"activeCount":87},[],{"trials":186,"activeCount":87},[],{"trials":188,"activeCount":87},[],{"trials":190,"activeCount":87},[],{"intervention":53,"totalTrials":83,"cells":192},{"EARLY_PHASE1":193,"PHASE1":203,"PHASE2":205,"PHASE3":207,"PHASE4":209,"NA":211},{"trials":194,"activeCount":83,"soonestReadout":52},[195],{"nctId":50,"briefTitle":51,"status":116,"phases":196,"primaryCompletion":52,"completion":197,"start":198,"enrollment":199,"conditions":200,"interventions":202},[75],"2028-01-01","2026-07-01",80,[201],"Encopresis With Constipation and Overflow Incontinence",[53],{"trials":204,"activeCount":87},[],{"trials":206,"activeCount":87},[],{"trials":208,"activeCount":87},[],{"trials":210,"activeCount":87},[],{"trials":212,"activeCount":87},[],{"intervention":48,"totalTrials":83,"cells":214},{"EARLY_PHASE1":215,"PHASE1":227,"PHASE2":229,"PHASE3":231,"PHASE4":233,"NA":235},{"trials":216,"activeCount":83,"soonestReadout":47},[217],{"nctId":45,"briefTitle":46,"status":116,"phases":218,"primaryCompletion":47,"completion":219,"start":220,"enrollment":221,"conditions":222,"interventions":225},[75],"2027-06","2025-03",150,[223,224],"Ivf","Frozen Embryo Transfer (FET)",[48,226],"Utrogestan®",{"trials":228,"activeCount":87},[],{"trials":230,"activeCount":87},[],{"trials":232,"activeCount":87},[],{"trials":234,"activeCount":87},[],{"trials":236,"activeCount":87},[],{"intervention":226,"totalTrials":83,"cells":238},{"EARLY_PHASE1":239,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":253},{"trials":240,"activeCount":83,"soonestReadout":47},[241],{"nctId":45,"briefTitle":46,"status":116,"phases":242,"primaryCompletion":47,"completion":219,"start":220,"enrollment":221,"conditions":243,"interventions":244},[75],[223,224],[48,226],{"trials":246,"activeCount":87},[],{"trials":248,"activeCount":87},[],{"trials":250,"activeCount":87},[],{"trials":252,"activeCount":87},[],{"trials":254,"activeCount":87},[],{"intervention":43,"totalTrials":83,"cells":256},{"EARLY_PHASE1":257,"PHASE1":259,"PHASE2":261,"PHASE3":263,"PHASE4":265,"NA":267},{"trials":258,"activeCount":87},[],{"trials":260,"activeCount":87},[],{"trials":262,"activeCount":87},[],{"trials":264,"activeCount":87},[],{"trials":266,"activeCount":87},[],{"trials":268,"activeCount":83,"soonestReadout":42},[269],{"nctId":40,"briefTitle":41,"status":93,"phases":270,"primaryCompletion":42,"completion":42,"start":271,"enrollment":272,"conditions":273,"interventions":275},[80],"2024-10-31",90,[274],"Crohn Disease",[43],{"intervention":68,"totalTrials":83,"cells":277},{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":288},{"trials":279,"activeCount":87},[],{"trials":281,"activeCount":87},[],{"trials":283,"activeCount":87},[],{"trials":285,"activeCount":87},[],{"trials":287,"activeCount":87},[],{"trials":289,"activeCount":83,"soonestReadout":67},[290],{"nctId":65,"briefTitle":66,"status":116,"phases":291,"primaryCompletion":67,"completion":67,"start":292,"enrollment":293,"conditions":294,"interventions":296},[80],"2026-05-01",32,[295],"Esophageal Stricture",[68],{"intervention":298,"totalTrials":299,"cells":300},"Varenicline",2,{"EARLY_PHASE1":301,"PHASE1":303,"PHASE2":305,"PHASE3":307,"PHASE4":309,"NA":332},{"trials":302,"activeCount":87},[],{"trials":304,"activeCount":87},[],{"trials":306,"activeCount":87},[],{"trials":308,"activeCount":87},[],{"trials":310,"activeCount":87},[311,322],{"nctId":312,"briefTitle":313,"status":314,"phases":315,"primaryCompletion":316,"completion":316,"start":317,"enrollment":318,"conditions":319,"interventions":321},"NCT02634281","Extended (6-Week) Varenicline Preloading: Does it Facilitate Smoking Reduction and Cessation?","COMPLETED",[79],"2018-06-28","2016-02",242,[320],"Smoking Cessation",[298],{"nctId":323,"briefTitle":324,"status":325,"phases":326,"primaryCompletion":327,"completion":327,"start":328,"enrollment":329,"conditions":330,"interventions":331},"NCT02894957","Varenicline for \"Gradual\" vs. \"Abrupt\" Smoking Cessation in Low-motivated COPD Smokers","UNKNOWN",[79],"2019-12","2019-10",250,[320],[298],{"trials":333,"activeCount":87},[],{"intervention":335,"totalTrials":299,"cells":336},"VPRIV",{"EARLY_PHASE1":337,"PHASE1":339,"PHASE2":341,"PHASE3":343,"PHASE4":345,"NA":366},{"trials":338,"activeCount":87},[],{"trials":340,"activeCount":87},[],{"trials":342,"activeCount":87},[],{"trials":344,"activeCount":87},[],{"trials":346,"activeCount":87},[347,356],{"nctId":348,"briefTitle":349,"status":314,"phases":350,"primaryCompletion":351,"completion":352,"start":353,"enrollment":97,"conditions":354,"interventions":355},"NCT04120506","Long Term Impact of Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV)",[79],"2017-01-20","2022-01-01","2016-01-10",[28],[335],{"nctId":357,"briefTitle":358,"status":314,"phases":359,"primaryCompletion":360,"completion":361,"start":362,"enrollment":97,"conditions":363,"interventions":365},"NCT03702361","Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV) in Treatment-naive Patients With Type 1 Gaucher Disease",[79],"2019-09-30","2021-03-18","2018-09-04",[364],"Primary Disease",[335],{"trials":367,"activeCount":87},[],{"intervention":369,"totalTrials":299,"cells":370},"METHYLPHENIDATE",{"EARLY_PHASE1":371,"PHASE1":373,"PHASE2":375,"PHASE3":387,"PHASE4":389,"NA":401},{"trials":372,"activeCount":87},[],{"trials":374,"activeCount":87},[],{"trials":376,"activeCount":87},[377],{"nctId":378,"briefTitle":379,"status":314,"phases":380,"primaryCompletion":381,"completion":381,"start":382,"enrollment":383,"conditions":384,"interventions":385},"NCT00364702","Virtual Reality a Novel Screening and Treatment Aid in Attention Deficit Disorder",[77],"2007-07","2006-08",40,[30],[386],"methylphenidate",{"trials":388,"activeCount":87},[],{"trials":390,"activeCount":87},[391],{"nctId":392,"briefTitle":393,"status":325,"phases":394,"primaryCompletion":395,"completion":395,"start":396,"enrollment":397,"conditions":398,"interventions":400},"NCT00815841","Methylphenidate in Healthy Young Adults",[79],"2009-12","2009-01",50,[399],"Healthy",[369],{"trials":402,"activeCount":87},[],{"intervention":404,"totalTrials":83,"cells":405},"Oxytocin",{"EARLY_PHASE1":406,"PHASE1":408,"PHASE2":410,"PHASE3":412,"PHASE4":414,"NA":427},{"trials":407,"activeCount":87},[],{"trials":409,"activeCount":87},[],{"trials":411,"activeCount":87},[],{"trials":413,"activeCount":87},[],{"trials":415,"activeCount":87},[416],{"nctId":417,"briefTitle":418,"status":325,"phases":419,"primaryCompletion":420,"completion":420,"start":421,"enrollment":422,"conditions":423,"interventions":425},"NCT02801227","Oxytocin vs. Prostaglandin for Induction of Labor in Primiparas With Prelabor Rupture of Membrane and Low Bishop",[79],"2017-09","2016-09",68,[424],"Premature Rupture of Fetal Membranes",[404,426],"Prostaglandin E2",{"trials":428,"activeCount":87},[],{"intervention":426,"totalTrials":83,"cells":430},{"EARLY_PHASE1":431,"PHASE1":433,"PHASE2":435,"PHASE3":437,"PHASE4":439,"NA":445},{"trials":432,"activeCount":87},[],{"trials":434,"activeCount":87},[],{"trials":436,"activeCount":87},[],{"trials":438,"activeCount":87},[],{"trials":440,"activeCount":87},[441],{"nctId":417,"briefTitle":418,"status":325,"phases":442,"primaryCompletion":420,"completion":420,"start":421,"enrollment":422,"conditions":443,"interventions":444},[79],[424],[404,426],{"trials":446,"activeCount":87},[],{"intervention":448,"totalTrials":83,"cells":449},"Enoxaparine",{"EARLY_PHASE1":450,"PHASE1":452,"PHASE2":454,"PHASE3":456,"PHASE4":458,"NA":472},{"trials":451,"activeCount":87},[],{"trials":453,"activeCount":87},[],{"trials":455,"activeCount":87},[],{"trials":457,"activeCount":87},[],{"trials":459,"activeCount":87},[460],{"nctId":461,"briefTitle":462,"status":314,"phases":463,"primaryCompletion":464,"completion":465,"start":466,"enrollment":467,"conditions":468,"interventions":471},"NCT00351663","The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients",[79],"2014-04","2015-09","2007-02",39,[469,470],"Venous Thrombosis","Critical Illness",[448],{"trials":473,"activeCount":87},[],{"intervention":475,"totalTrials":83,"cells":476},"Azathioprine",{"EARLY_PHASE1":477,"PHASE1":479,"PHASE2":481,"PHASE3":483,"PHASE4":485,"NA":497},{"trials":478,"activeCount":87},[],{"trials":480,"activeCount":87},[],{"trials":482,"activeCount":87},[],{"trials":484,"activeCount":87},[],{"trials":486,"activeCount":87},[487],{"nctId":488,"briefTitle":489,"status":490,"phases":491,"primaryCompletion":492,"completion":492,"start":493,"enrollment":87,"conditions":494,"interventions":496},"NCT02281799","Thiopurine Induced Pancreatitis in IBD Patients","WITHDRAWN",[79],"2018-01","2015-03",[495,26],"Pancreatitis",[475],{"trials":498,"activeCount":87},[],{"intervention":500,"totalTrials":83,"cells":501},"caudal anesthesia",{"EARLY_PHASE1":502,"PHASE1":504,"PHASE2":506,"PHASE3":508,"PHASE4":510,"NA":523},{"trials":503,"activeCount":87},[],{"trials":505,"activeCount":87},[],{"trials":507,"activeCount":87},[],{"trials":509,"activeCount":87},[],{"trials":511,"activeCount":87},[512],{"nctId":513,"briefTitle":514,"status":314,"phases":515,"primaryCompletion":516,"completion":517,"start":518,"enrollment":383,"conditions":519,"interventions":521},"NCT01869036","Use of Caudal Anesthesia Supplemented With Morphine in Children Undergoing Renal Surgery",[79],"2013-10","2013-11","2012-07",[520],"Anesthesia, Caudal",[500,522],"caudal anesthesia supplemented with morphine",{"trials":524,"activeCount":87},[],{"intervention":522,"totalTrials":83,"cells":526},{"EARLY_PHASE1":527,"PHASE1":529,"PHASE2":531,"PHASE3":533,"PHASE4":535,"NA":541},{"trials":528,"activeCount":87},[],{"trials":530,"activeCount":87},[],{"trials":532,"activeCount":87},[],{"trials":534,"activeCount":87},[],{"trials":536,"activeCount":87},[537],{"nctId":513,"briefTitle":514,"status":314,"phases":538,"primaryCompletion":516,"completion":517,"start":518,"enrollment":383,"conditions":539,"interventions":540},[79],[520],[500,522],{"trials":542,"activeCount":87},[],{"intervention":544,"totalTrials":83,"cells":545},"L- DOPA",{"EARLY_PHASE1":546,"PHASE1":548,"PHASE2":550,"PHASE3":552,"PHASE4":554,"NA":566},{"trials":547,"activeCount":87},[],{"trials":549,"activeCount":87},[],{"trials":551,"activeCount":87},[],{"trials":553,"activeCount":87},[],{"trials":555,"activeCount":87},[556],{"nctId":557,"briefTitle":558,"status":325,"phases":559,"primaryCompletion":560,"completion":561,"start":562,"enrollment":397,"conditions":563,"interventions":565},"NCT01361373","Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study",[79],"2012-05","2012-08","2010-05",[564],"Dystonic Cerebral Palsy",[544],{"trials":567,"activeCount":87},[],{"intervention":569,"totalTrials":83,"cells":570},"etoricoxib",{"EARLY_PHASE1":571,"PHASE1":573,"PHASE2":575,"PHASE3":577,"PHASE4":579,"NA":591},{"trials":572,"activeCount":87},[],{"trials":574,"activeCount":87},[],{"trials":576,"activeCount":87},[],{"trials":578,"activeCount":87},[],{"trials":580,"activeCount":87},[581],{"nctId":582,"briefTitle":583,"status":325,"phases":584,"primaryCompletion":585,"completion":585,"start":586,"enrollment":587,"conditions":588,"interventions":590},"NCT00752921","Randomized Placebo Controlled Trial With Etoricoxib That is Taken to Prevent the Yom Kippur Headache",[79],"2008-10","2008-09",200,[589],"Headache",[569],{"trials":592,"activeCount":87},[],{"intervention":594,"totalTrials":83,"cells":595},"Pregabalin",{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":602,"PHASE4":604,"NA":616},{"trials":597,"activeCount":87},[],{"trials":599,"activeCount":87},[],{"trials":601,"activeCount":87},[],{"trials":603,"activeCount":87},[],{"trials":605,"activeCount":87},[606],{"nctId":607,"briefTitle":608,"status":325,"phases":609,"primaryCompletion":610,"completion":610,"start":611,"enrollment":612,"conditions":613,"interventions":615},"NCT01073501","Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus",[79],"2012-03","2010-04",36,[614],"Uremic Pruritus",[594],{"trials":617,"activeCount":87},[],{"intervention":619,"totalTrials":83,"cells":620},"Eplerenone",{"EARLY_PHASE1":621,"PHASE1":623,"PHASE2":625,"PHASE3":627,"PHASE4":629,"NA":643},{"trials":622,"activeCount":87},[],{"trials":624,"activeCount":87},[],{"trials":626,"activeCount":87},[],{"trials":628,"activeCount":87},[],{"trials":630,"activeCount":87},[631],{"nctId":632,"briefTitle":633,"status":325,"phases":634,"completion":635,"start":636,"enrollment":637,"conditions":638,"interventions":642},"NCT00553722","Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?",[79],"2009-11","2007-11",27,[639,640,641],"Hypertension","Dialysis","Hyperaldosteronism",[619],{"trials":644,"activeCount":87},[],{"intervention":646,"totalTrials":83,"cells":647},"Ursodeoxycholic Acid",{"EARLY_PHASE1":648,"PHASE1":650,"PHASE2":652,"PHASE3":654,"PHASE4":656,"NA":670},{"trials":649,"activeCount":87},[],{"trials":651,"activeCount":87},[],{"trials":653,"activeCount":87},[],{"trials":655,"activeCount":87},[],{"trials":657,"activeCount":87},[658],{"nctId":659,"briefTitle":660,"status":661,"phases":662,"primaryCompletion":663,"completion":663,"start":664,"enrollment":665,"conditions":666,"interventions":669},"NCT02472509","The Role of Ursodeoxycholic Acid in Treatment of Gallstones in Hemolytic Disorders","TERMINATED",[79],"2017-09-10","2014-12",3,[667,668],"Hemolytic Disorders","Gallstones",[646],{"trials":671,"activeCount":87},[],{"intervention":673,"totalTrials":83,"cells":674},"oral baclofen + placebo",{"EARLY_PHASE1":675,"PHASE1":677,"PHASE2":679,"PHASE3":681,"PHASE4":683,"NA":693},{"trials":676,"activeCount":87},[],{"trials":678,"activeCount":87},[],{"trials":680,"activeCount":87},[],{"trials":682,"activeCount":87},[],{"trials":684,"activeCount":87},[685],{"nctId":686,"briefTitle":687,"status":661,"phases":688,"primaryCompletion":689,"completion":689,"start":690,"enrollment":141,"conditions":691,"interventions":692},"NCT00752934","Does Oral Baclofen Improve Care and Comfort in Spastic Children in Nursing Homes?",[79],"2015-06","2010-10",[18],[673],{"trials":694,"activeCount":87},[],{"intervention":696,"totalTrials":22,"cells":697},"Traumeel S",{"EARLY_PHASE1":698,"PHASE1":700,"PHASE2":702,"PHASE3":704,"PHASE4":744,"NA":746},{"trials":699,"activeCount":87},[],{"trials":701,"activeCount":87},[],{"trials":703,"activeCount":87},[],{"trials":705,"activeCount":87},[706,717,726,735],{"nctId":707,"briefTitle":708,"status":490,"phases":709,"primaryCompletion":710,"start":711,"enrollment":712,"conditions":713,"interventions":716},"NCT00307905","TRAUMEEL for Pain After Fracture of Neck of Femur",[78],"2012-06","2011-01",224,[714,715],"Pain","Fracture of Neck of Femur",[696],{"nctId":718,"briefTitle":719,"status":661,"phases":720,"primaryCompletion":721,"start":722,"enrollment":712,"conditions":723,"interventions":725},"NCT00307853","TRAUMEEL for Pain After Total Knee\u002FHip Arthroplasty",[78],"2009-08","2008-08",[724],"Total Knee and Total Hip Arthroplasty",[696],{"nctId":727,"briefTitle":728,"status":314,"phases":729,"primaryCompletion":730,"completion":730,"start":731,"conditions":732,"interventions":734},"NCT00279513","TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial",[78],"2007-12","2006-09",[733],"Post Hallux Valgus Repair Pain",[696],{"nctId":736,"briefTitle":737,"status":325,"phases":738,"primaryCompletion":739,"start":740,"enrollment":141,"conditions":741,"interventions":743},"NCT00410332","Traumeel for Post-Tonsillectomy Pain",[78],"2012-12","2011-03",[742],"Post-Tonsillectomy",[696],{"trials":745,"activeCount":87},[],{"trials":747,"activeCount":87},[],{"intervention":749,"totalTrials":665,"cells":750},"ibuprofen",{"EARLY_PHASE1":751,"PHASE1":753,"PHASE2":755,"PHASE3":775,"PHASE4":786,"NA":788},{"trials":752,"activeCount":87},[],{"trials":754,"activeCount":87},[],{"trials":756,"activeCount":87},[757,766],{"nctId":758,"briefTitle":759,"status":314,"phases":760,"completion":761,"enrollment":762,"conditions":763,"interventions":765},"NCT00954200","Ibuprofen as a Possible Preventer of Post Bronchoscopy Fever",[77],"2015-01",64,[764],"Post Bronchoscopy Fever",[749,749],{"nctId":767,"briefTitle":768,"status":490,"phases":769,"primaryCompletion":710,"start":770,"enrollment":87,"conditions":771,"interventions":772},"NCT01070745","Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)",[77],"2010-06",[15],[773,774],"Indomethacin","Ibuprofen",{"trials":776,"activeCount":87},[777],{"nctId":778,"briefTitle":779,"status":314,"phases":780,"completion":731,"start":781,"enrollment":782,"conditions":783,"interventions":784},"NCT00485160","Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA",[78],"2002-02",70,[15],[785,749],"Continuous indomethacin",{"trials":787,"activeCount":87},[],{"trials":789,"activeCount":87},[],{"intervention":791,"totalTrials":83,"cells":792},"Homeopathic placebo medication",{"EARLY_PHASE1":793,"PHASE1":795,"PHASE2":797,"PHASE3":799,"PHASE4":811,"NA":813},{"trials":794,"activeCount":87},[],{"trials":796,"activeCount":87},[],{"trials":798,"activeCount":87},[],{"trials":800,"activeCount":87},[801],{"nctId":802,"briefTitle":803,"status":325,"phases":804,"primaryCompletion":516,"completion":516,"start":805,"enrollment":806,"conditions":807,"interventions":810},"NCT01650363","CAM in Post Surgical Management in Cardiothoracic Surgery",[78],"2012-10",100,[808,809],"Patients Undergoing Open Heart Surgery","Patients Undergoing Lung Surgery",[791],{"trials":812,"activeCount":87},[],{"trials":814,"activeCount":87},[],{"intervention":816,"totalTrials":83,"cells":817},"Rectal Solution",{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":822,"PHASE3":824,"PHASE4":837,"NA":839},{"trials":819,"activeCount":87},[],{"trials":821,"activeCount":87},[],{"trials":823,"activeCount":87},[],{"trials":825,"activeCount":87},[826],{"nctId":827,"briefTitle":828,"status":325,"phases":829,"primaryCompletion":830,"completion":831,"start":832,"enrollment":199,"conditions":833,"interventions":835},"NCT03604796","Alternative Paracetamol Treatments for the Neonate With a hsPDA",[77,78],"2021-09","2022-01","2018-09",[834],"Ductus Arteriosus, Patent",[816,836],"Intravenous",{"trials":838,"activeCount":87},[],{"trials":840,"activeCount":87},[],{"intervention":836,"totalTrials":83,"cells":842},{"EARLY_PHASE1":843,"PHASE1":845,"PHASE2":847,"PHASE3":849,"PHASE4":855,"NA":857},{"trials":844,"activeCount":87},[],{"trials":846,"activeCount":87},[],{"trials":848,"activeCount":87},[],{"trials":850,"activeCount":87},[851],{"nctId":827,"briefTitle":828,"status":325,"phases":852,"primaryCompletion":830,"completion":831,"start":832,"enrollment":199,"conditions":853,"interventions":854},[77,78],[834],[816,836],{"trials":856,"activeCount":87},[],{"trials":858,"activeCount":87},[],{"intervention":860,"totalTrials":83,"cells":861},"Homeopathy 1",{"EARLY_PHASE1":862,"PHASE1":864,"PHASE2":866,"PHASE3":868,"PHASE4":880,"NA":882},{"trials":863,"activeCount":87},[],{"trials":865,"activeCount":87},[],{"trials":867,"activeCount":87},[],{"trials":869,"activeCount":87},[870],{"nctId":871,"briefTitle":872,"status":314,"phases":873,"primaryCompletion":874,"completion":874,"start":711,"enrollment":875,"conditions":876,"interventions":878},"NCT01156194","Homeopathic Remedy for the Third Stage of Delivery",[78],"2012-01",210,[877],"Third Stage of Labor",[860,879],"Homeopathy 2",{"trials":881,"activeCount":87},[],{"trials":883,"activeCount":87},[],{"intervention":879,"totalTrials":83,"cells":885},{"EARLY_PHASE1":886,"PHASE1":888,"PHASE2":890,"PHASE3":892,"PHASE4":898,"NA":900},{"trials":887,"activeCount":87},[],{"trials":889,"activeCount":87},[],{"trials":891,"activeCount":87},[],{"trials":893,"activeCount":87},[894],{"nctId":871,"briefTitle":872,"status":314,"phases":895,"primaryCompletion":874,"completion":874,"start":711,"enrollment":875,"conditions":896,"interventions":897},[78],[877],[860,879],{"trials":899,"activeCount":87},[],{"trials":901,"activeCount":87},[],{"intervention":903,"totalTrials":83,"cells":904},"Intragel",{"EARLY_PHASE1":905,"PHASE1":907,"PHASE2":909,"PHASE3":911,"PHASE4":924,"NA":926},{"trials":906,"activeCount":87},[],{"trials":908,"activeCount":87},[],{"trials":910,"activeCount":87},[],{"trials":912,"activeCount":87},[913],{"nctId":914,"briefTitle":915,"status":314,"phases":916,"primaryCompletion":917,"completion":917,"start":918,"enrollment":919,"conditions":920,"interventions":922},"NCT02258295","Hyaluronate Injection for Lateral Epicondylitis",[78],"2019-09-01","2017-01-18",35,[921],"Tennis Elbow",[903,923],"Saline",{"trials":925,"activeCount":87},[],{"trials":927,"activeCount":87},[],{"intervention":923,"totalTrials":83,"cells":929},{"EARLY_PHASE1":930,"PHASE1":932,"PHASE2":934,"PHASE3":936,"PHASE4":942,"NA":944},{"trials":931,"activeCount":87},[],{"trials":933,"activeCount":87},[],{"trials":935,"activeCount":87},[],{"trials":937,"activeCount":87},[938],{"nctId":914,"briefTitle":915,"status":314,"phases":939,"primaryCompletion":917,"completion":917,"start":918,"enrollment":919,"conditions":940,"interventions":941},[78],[921],[903,923],{"trials":943,"activeCount":87},[],{"trials":945,"activeCount":87},[],{"intervention":947,"totalTrials":83,"cells":948},"Kali bichromicum 10-60",{"EARLY_PHASE1":949,"PHASE1":951,"PHASE2":953,"PHASE3":955,"PHASE4":966,"NA":968},{"trials":950,"activeCount":87},[],{"trials":952,"activeCount":87},[],{"trials":954,"activeCount":87},[],{"trials":956,"activeCount":87},[957],{"nctId":958,"briefTitle":959,"status":325,"phases":960,"start":961,"enrollment":962,"conditions":963,"interventions":965},"NCT00326365","Effect of Homeopathic Remedy Kalium Bichromicum on Viscosity and Amount of Sputum Mechanically Ventilated ICU Patients.",[78],"2006-06",56,[964],"Mechanically Ventilated ICU Patients",[947],{"trials":967,"activeCount":87},[],{"trials":969,"activeCount":87},[],{"intervention":971,"totalTrials":83,"cells":972},"Potassium Dichromate",{"EARLY_PHASE1":973,"PHASE1":975,"PHASE2":977,"PHASE3":979,"PHASE4":989,"NA":991},{"trials":974,"activeCount":87},[],{"trials":976,"activeCount":87},[],{"trials":978,"activeCount":87},[],{"trials":980,"activeCount":87},[981],{"nctId":982,"briefTitle":983,"status":325,"phases":984,"primaryCompletion":739,"completion":739,"start":985,"enrollment":962,"conditions":986,"interventions":988},"NCT00473473","Effect of the Homeopathic Remedy Kalium Bichromicum (Potassium Dichromate) on Viscosity and Amount of Sputum and Time to Extubation in Mechanically Ventilated ICU Patients.",[78],"2008-07",[987],"Mechanical Ventilation",[971],{"trials":990,"activeCount":87},[],{"trials":992,"activeCount":87},[],{"intervention":994,"totalTrials":83,"cells":995},"Bellis perennis and Staphysagria",{"EARLY_PHASE1":996,"PHASE1":998,"PHASE2":1000,"PHASE3":1002,"PHASE4":1012,"NA":1014},{"trials":997,"activeCount":87},[],{"trials":999,"activeCount":87},[],{"trials":1001,"activeCount":87},[],{"trials":1003,"activeCount":87},[1004],{"nctId":1005,"briefTitle":1006,"status":314,"phases":1007,"primaryCompletion":1008,"completion":1008,"start":722,"enrollment":272,"conditions":1009,"interventions":1011},"NCT00725569","Homeopathy for Post-operative (C. Section) Recovery",[77,78],"2009-04",[1010],"Cesarean Section",[994,994],{"trials":1013,"activeCount":87},[],{"trials":1015,"activeCount":87},[],{"intervention":785,"totalTrials":83,"cells":1017},{"EARLY_PHASE1":1018,"PHASE1":1020,"PHASE2":1022,"PHASE3":1024,"PHASE4":1030,"NA":1032},{"trials":1019,"activeCount":87},[],{"trials":1021,"activeCount":87},[],{"trials":1023,"activeCount":87},[],{"trials":1025,"activeCount":87},[1026],{"nctId":778,"briefTitle":779,"status":314,"phases":1027,"completion":731,"start":781,"enrollment":782,"conditions":1028,"interventions":1029},[78],[15],[785,749],{"trials":1031,"activeCount":87},[],{"trials":1033,"activeCount":87},[],{"intervention":1035,"totalTrials":83,"cells":1036},"Traumeel S: intra-operative irrigation + oral ingestion",{"EARLY_PHASE1":1037,"PHASE1":1039,"PHASE2":1041,"PHASE3":1043,"PHASE4":1054,"NA":1056},{"trials":1038,"activeCount":87},[],{"trials":1040,"activeCount":87},[],{"trials":1042,"activeCount":87},[],{"trials":1044,"activeCount":87},[1045],{"nctId":1046,"briefTitle":1047,"status":1048,"phases":1049,"primaryCompletion":874,"start":711,"enrollment":1050,"conditions":1051,"interventions":1053},"NCT00307892","Traumeel S for Reduction of Post Operative Pain Following Arthroscopy","SUSPENDED",[78],98,[1052],"Post-operative Pain",[1035],{"trials":1055,"activeCount":87},[],{"trials":1057,"activeCount":87},[],{"intervention":1059,"totalTrials":83,"cells":1060},"paclitaxel",{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1067,"PHASE4":1080,"NA":1082},{"trials":1062,"activeCount":87},[],{"trials":1064,"activeCount":87},[],{"trials":1066,"activeCount":87},[],{"trials":1068,"activeCount":87},[1069],{"nctId":1070,"briefTitle":1071,"status":661,"phases":1072,"primaryCompletion":1073,"completion":1074,"start":1075,"enrollment":1076,"conditions":1077,"interventions":1079},"NCT02368197","Drug Eluting Balloon Angioplasty for Recurrent Cephalic Arch Stenosis in Dialysis Fistulas",[77,78],"2017-05","2017-12","2015-07",13,[1078],"Dialysis Access Dysfunction",[1059],{"trials":1081,"activeCount":87},[],{"trials":1083,"activeCount":87},[],{"intervention":1085,"totalTrials":83,"cells":1086},"Natrum muriaticum 30C",{"EARLY_PHASE1":1087,"PHASE1":1089,"PHASE2":1091,"PHASE3":1093,"PHASE4":1109,"NA":1111},{"trials":1088,"activeCount":87},[],{"trials":1090,"activeCount":87},[],{"trials":1092,"activeCount":87},[],{"trials":1094,"activeCount":87},[1095],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1098,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1101,"interventions":1103},"NCT02402049","Homeopathic Treatment of Premenstrual Syndrome",[78],"2016-03",180,[1102],"Premenstrual Syndrome-PMS",[1085,1104,1105,1106,1107,1108],"Lachesis 30C","Sepia 30C","Nux vomica 30C","Pulsatilla 30C","Folliculinum 30C",{"trials":1110,"activeCount":87},[],{"trials":1112,"activeCount":87},[],{"intervention":1104,"totalTrials":83,"cells":1114},{"EARLY_PHASE1":1115,"PHASE1":1117,"PHASE2":1119,"PHASE3":1121,"PHASE4":1127,"NA":1129},{"trials":1116,"activeCount":87},[],{"trials":1118,"activeCount":87},[],{"trials":1120,"activeCount":87},[],{"trials":1122,"activeCount":87},[1123],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1124,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1125,"interventions":1126},[78],[1102],[1085,1104,1105,1106,1107,1108],{"trials":1128,"activeCount":87},[],{"trials":1130,"activeCount":87},[],{"intervention":1105,"totalTrials":83,"cells":1132},{"EARLY_PHASE1":1133,"PHASE1":1135,"PHASE2":1137,"PHASE3":1139,"PHASE4":1145,"NA":1147},{"trials":1134,"activeCount":87},[],{"trials":1136,"activeCount":87},[],{"trials":1138,"activeCount":87},[],{"trials":1140,"activeCount":87},[1141],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1142,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1143,"interventions":1144},[78],[1102],[1085,1104,1105,1106,1107,1108],{"trials":1146,"activeCount":87},[],{"trials":1148,"activeCount":87},[],{"intervention":1106,"totalTrials":83,"cells":1150},{"EARLY_PHASE1":1151,"PHASE1":1153,"PHASE2":1155,"PHASE3":1157,"PHASE4":1163,"NA":1165},{"trials":1152,"activeCount":87},[],{"trials":1154,"activeCount":87},[],{"trials":1156,"activeCount":87},[],{"trials":1158,"activeCount":87},[1159],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1160,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1161,"interventions":1162},[78],[1102],[1085,1104,1105,1106,1107,1108],{"trials":1164,"activeCount":87},[],{"trials":1166,"activeCount":87},[],{"intervention":1107,"totalTrials":83,"cells":1168},{"EARLY_PHASE1":1169,"PHASE1":1171,"PHASE2":1173,"PHASE3":1175,"PHASE4":1181,"NA":1183},{"trials":1170,"activeCount":87},[],{"trials":1172,"activeCount":87},[],{"trials":1174,"activeCount":87},[],{"trials":1176,"activeCount":87},[1177],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1178,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1179,"interventions":1180},[78],[1102],[1085,1104,1105,1106,1107,1108],{"trials":1182,"activeCount":87},[],{"trials":1184,"activeCount":87},[],{"intervention":1108,"totalTrials":83,"cells":1186},{"EARLY_PHASE1":1187,"PHASE1":1189,"PHASE2":1191,"PHASE3":1193,"PHASE4":1199,"NA":1201},{"trials":1188,"activeCount":87},[],{"trials":1190,"activeCount":87},[],{"trials":1192,"activeCount":87},[],{"trials":1194,"activeCount":87},[1195],{"nctId":1096,"briefTitle":1097,"status":325,"phases":1196,"primaryCompletion":1099,"completion":1099,"start":493,"enrollment":1100,"conditions":1197,"interventions":1198},[78],[1102],[1085,1104,1105,1106,1107,1108],{"trials":1200,"activeCount":87},[],{"trials":1202,"activeCount":87},[],{"intervention":773,"totalTrials":299,"cells":1204},{"EARLY_PHASE1":1205,"PHASE1":1207,"PHASE2":1209,"PHASE3":1224,"PHASE4":1226,"NA":1228},{"trials":1206,"activeCount":87},[],{"trials":1208,"activeCount":87},[],{"trials":1210,"activeCount":87},[1211,1220],{"nctId":1212,"briefTitle":1213,"status":325,"phases":1214,"primaryCompletion":1215,"start":1216,"enrollment":422,"conditions":1217,"interventions":1218},"NCT00616382","Treating the Resistant Patent Ductus Arteriosus (PDA)",[77],"2010-03","2008-03",[15],[773,1219],"Pentoxifylline",{"nctId":767,"briefTitle":768,"status":490,"phases":1221,"primaryCompletion":710,"start":770,"enrollment":87,"conditions":1222,"interventions":1223},[77],[15],[773,774],{"trials":1225,"activeCount":87},[],{"trials":1227,"activeCount":87},[],{"trials":1229,"activeCount":87},[],{"intervention":1219,"totalTrials":299,"cells":1231},{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1251,"PHASE4":1253,"NA":1255},{"trials":1233,"activeCount":87},[],{"trials":1235,"activeCount":87},[],{"trials":1237,"activeCount":87},[1238,1242],{"nctId":1212,"briefTitle":1213,"status":325,"phases":1239,"primaryCompletion":1215,"start":1216,"enrollment":422,"conditions":1240,"interventions":1241},[77],[15],[773,1219],{"nctId":1243,"briefTitle":1244,"status":325,"phases":1245,"primaryCompletion":1246,"completion":1215,"start":1247,"enrollment":397,"conditions":1248,"interventions":1250},"NCT00271336","Pentoxifylline in the Treatment of NEC in Premature Neonates",[77],"2009-03","2005-01",[1249],"Necrotizing Enterocolitis",[1219],{"trials":1252,"activeCount":87},[],{"trials":1254,"activeCount":87},[],{"trials":1256,"activeCount":87},[],{"intervention":1258,"totalTrials":83,"cells":1259},"Tagrisso",{"EARLY_PHASE1":1260,"PHASE1":1262,"PHASE2":1264,"PHASE3":1275,"PHASE4":1277,"NA":1279},{"trials":1261,"activeCount":87},[],{"trials":1263,"activeCount":87},[],{"trials":1265,"activeCount":87},[1266],{"nctId":1267,"briefTitle":1268,"status":325,"phases":1269,"primaryCompletion":1270,"completion":1270,"start":1271,"enrollment":383,"conditions":1272,"interventions":1274},"NCT02824952","Neo-adjuvant Trial With AZD9291 in EGFRm+ Stage IIIA\u002FB NSCLC",[77],"2022-12","2018-11-01",[1273],"Lung Cancer, Non-small Cell",[1258],{"trials":1276,"activeCount":87},[],{"trials":1278,"activeCount":87},[],{"trials":1280,"activeCount":87},[],{"intervention":1282,"totalTrials":83,"cells":1283},"Ambroxol",{"EARLY_PHASE1":1284,"PHASE1":1286,"PHASE2":1288,"PHASE3":1299,"PHASE4":1301,"NA":1303},{"trials":1285,"activeCount":87},[],{"trials":1287,"activeCount":87},[],{"trials":1289,"activeCount":87},[1290],{"nctId":1291,"briefTitle":1292,"status":314,"phases":1293,"primaryCompletion":1294,"completion":1295,"start":1296,"enrollment":383,"conditions":1297,"interventions":1298},"NCT03950050","Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy",[77],"2022-11-30","2022-12-30","2019-03-01",[28],[1282],{"trials":1300,"activeCount":87},[],{"trials":1302,"activeCount":87},[],{"trials":1304,"activeCount":87},[],{"intervention":1306,"totalTrials":83,"cells":1307},"Cannabinoids - 99% pure cannabinoids mix",{"EARLY_PHASE1":1308,"PHASE1":1310,"PHASE2":1312,"PHASE3":1325,"PHASE4":1327,"NA":1329},{"trials":1309,"activeCount":87},[],{"trials":1311,"activeCount":87},[],{"trials":1313,"activeCount":87},[1314],{"nctId":1315,"briefTitle":1316,"status":314,"phases":1317,"primaryCompletion":1318,"completion":1319,"start":1320,"enrollment":221,"conditions":1321,"interventions":1323},"NCT02956226","Cannabinoids for Behavioral Problems in Children With ASD",[77],"2018-10","2018-12","2017-01",[1322],"Autistic Disorder",[1306,1324],"Cannabinoids - whole plant extract",{"trials":1326,"activeCount":87},[],{"trials":1328,"activeCount":87},[],{"trials":1330,"activeCount":87},[],{"intervention":1324,"totalTrials":83,"cells":1332},{"EARLY_PHASE1":1333,"PHASE1":1335,"PHASE2":1337,"PHASE3":1343,"PHASE4":1345,"NA":1347},{"trials":1334,"activeCount":87},[],{"trials":1336,"activeCount":87},[],{"trials":1338,"activeCount":87},[1339],{"nctId":1315,"briefTitle":1316,"status":314,"phases":1340,"primaryCompletion":1318,"completion":1319,"start":1320,"enrollment":221,"conditions":1341,"interventions":1342},[77],[1322],[1306,1324],{"trials":1344,"activeCount":87},[],{"trials":1346,"activeCount":87},[],{"trials":1348,"activeCount":87},[],{"intervention":1350,"totalTrials":83,"cells":1351},"NSAID",{"EARLY_PHASE1":1352,"PHASE1":1354,"PHASE2":1356,"PHASE3":1367,"PHASE4":1369,"NA":1371},{"trials":1353,"activeCount":87},[],{"trials":1355,"activeCount":87},[],{"trials":1357,"activeCount":87},[1358],{"nctId":1359,"briefTitle":1360,"status":325,"phases":1361,"primaryCompletion":664,"start":1362,"enrollment":199,"conditions":1363,"interventions":1364},"NCT01291654","Paracetamol and Patent Ductus Arteriosus (PDA)",[77],"2012-04",[15],[1365,1350,1366],"Paracetamol","D5W",{"trials":1368,"activeCount":87},[],{"trials":1370,"activeCount":87},[],{"trials":1372,"activeCount":87},[],{"intervention":1366,"totalTrials":83,"cells":1374},{"EARLY_PHASE1":1375,"PHASE1":1377,"PHASE2":1379,"PHASE3":1385,"PHASE4":1387,"NA":1389},{"trials":1376,"activeCount":87},[],{"trials":1378,"activeCount":87},[],{"trials":1380,"activeCount":87},[1381],{"nctId":1359,"briefTitle":1360,"status":325,"phases":1382,"primaryCompletion":664,"start":1362,"enrollment":199,"conditions":1383,"interventions":1384},[77],[15],[1365,1350,1366],{"trials":1386,"activeCount":87},[],{"trials":1388,"activeCount":87},[],{"trials":1390,"activeCount":87},[],{"intervention":1392,"totalTrials":83,"cells":1393},"Lymphomyosot",{"EARLY_PHASE1":1394,"PHASE1":1396,"PHASE2":1398,"PHASE3":1410,"PHASE4":1412,"NA":1414},{"trials":1395,"activeCount":87},[],{"trials":1397,"activeCount":87},[],{"trials":1399,"activeCount":87},[1400],{"nctId":1401,"briefTitle":1402,"status":1048,"phases":1403,"primaryCompletion":739,"start":1404,"enrollment":1405,"conditions":1406,"interventions":1409},"NCT00884988","Lymphomyosot for Ankle Edema Following Fracture",[77],"2010-02",60,[1407,1408],"Ankle Injuries","Fracture",[1392],{"trials":1411,"activeCount":87},[],{"trials":1413,"activeCount":87},[],{"trials":1415,"activeCount":87},[],{"intervention":1417,"totalTrials":83,"cells":1418},"glucagon",{"EARLY_PHASE1":1419,"PHASE1":1421,"PHASE2":1423,"PHASE3":1433,"PHASE4":1435,"NA":1437},{"trials":1420,"activeCount":87},[],{"trials":1422,"activeCount":87},[],{"trials":1424,"activeCount":87},[1425],{"nctId":1426,"briefTitle":1427,"status":314,"phases":1428,"primaryCompletion":1429,"completion":1429,"start":730,"conditions":1430,"interventions":1432},"NCT00434772","Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers",[77],"2009-05",[1431],"Hypoglycemia",[1417],{"trials":1434,"activeCount":87},[],{"trials":1436,"activeCount":87},[],{"trials":1438,"activeCount":87},[],{"intervention":1440,"totalTrials":83,"cells":1441},"periopatch",{"EARLY_PHASE1":1442,"PHASE1":1444,"PHASE2":1446,"PHASE3":1455,"PHASE4":1457,"NA":1459},{"trials":1443,"activeCount":87},[],{"trials":1445,"activeCount":87},[],{"trials":1447,"activeCount":87},[1448],{"nctId":1449,"briefTitle":1450,"status":314,"phases":1451,"primaryCompletion":1246,"completion":1246,"start":636,"enrollment":1405,"conditions":1452,"interventions":1454},"NCT00554034","Effect of Herbal Extracts on Gingival Inflammation",[77],[1453],"Gingivitis",[1440],{"trials":1456,"activeCount":87},[],{"trials":1458,"activeCount":87},[],{"trials":1460,"activeCount":87},[],{"intervention":1462,"totalTrials":83,"cells":1463},"Paracetamol drops",{"EARLY_PHASE1":1464,"PHASE1":1466,"PHASE2":1468,"PHASE3":1479,"PHASE4":1481,"NA":1483},{"trials":1465,"activeCount":87},[],{"trials":1467,"activeCount":87},[],{"trials":1469,"activeCount":87},[1470],{"nctId":1471,"briefTitle":1472,"status":325,"phases":1473,"primaryCompletion":1474,"completion":1475,"start":1476,"enrollment":199,"conditions":1477,"interventions":1478},"NCT02819414","Paracetamol Treatment of the Borderline Significant PDA",[77],"2018-06","2019-01","2016-06",[15],[1462],{"trials":1480,"activeCount":87},[],{"trials":1482,"activeCount":87},[],{"trials":1484,"activeCount":87},[],{"intervention":1486,"totalTrials":83,"cells":1487},"Herbal API",{"EARLY_PHASE1":1488,"PHASE1":1490,"PHASE2":1492,"PHASE3":1504,"PHASE4":1506,"NA":1508},{"trials":1489,"activeCount":87},[],{"trials":1491,"activeCount":87},[],{"trials":1493,"activeCount":87},[1494],{"nctId":1495,"briefTitle":1496,"status":314,"phases":1497,"primaryCompletion":770,"completion":770,"start":1498,"enrollment":1499,"conditions":1500,"interventions":1501},"NCT00885599","Efficacy of a Naturally-derived Mouthrinse for Gingival Inflammation",[76,77],"2009-06",94,[1453],[1486,1502,1503],"Cepacol","Listerine Antiseptic Mouth Rinse",{"trials":1505,"activeCount":87},[],{"trials":1507,"activeCount":87},[],{"trials":1509,"activeCount":87},[],{"intervention":1502,"totalTrials":83,"cells":1511},{"EARLY_PHASE1":1512,"PHASE1":1514,"PHASE2":1516,"PHASE3":1522,"PHASE4":1524,"NA":1526},{"trials":1513,"activeCount":87},[],{"trials":1515,"activeCount":87},[],{"trials":1517,"activeCount":87},[1518],{"nctId":1495,"briefTitle":1496,"status":314,"phases":1519,"primaryCompletion":770,"completion":770,"start":1498,"enrollment":1499,"conditions":1520,"interventions":1521},[76,77],[1453],[1486,1502,1503],{"trials":1523,"activeCount":87},[],{"trials":1525,"activeCount":87},[],{"trials":1527,"activeCount":87},[],{"intervention":1503,"totalTrials":83,"cells":1529},{"EARLY_PHASE1":1530,"PHASE1":1532,"PHASE2":1534,"PHASE3":1540,"PHASE4":1542,"NA":1544},{"trials":1531,"activeCount":87},[],{"trials":1533,"activeCount":87},[],{"trials":1535,"activeCount":87},[1536],{"nctId":1495,"briefTitle":1496,"status":314,"phases":1537,"primaryCompletion":770,"completion":770,"start":1498,"enrollment":1499,"conditions":1538,"interventions":1539},[76,77],[1453],[1486,1502,1503],{"trials":1541,"activeCount":87},[],{"trials":1543,"activeCount":87},[],{"trials":1545,"activeCount":87},[],{"intervention":1547,"totalTrials":299,"cells":1548},"GnRH agonist",{"EARLY_PHASE1":1549,"PHASE1":1551,"PHASE2":1553,"PHASE3":1555,"PHASE4":1557,"NA":1559},{"trials":1550,"activeCount":87},[],{"trials":1552,"activeCount":87},[],{"trials":1554,"activeCount":87},[],{"trials":1556,"activeCount":87},[],{"trials":1558,"activeCount":87},[],{"trials":1560,"activeCount":87},[1561,1572],{"nctId":1562,"briefTitle":1563,"status":325,"phases":1564,"primaryCompletion":1565,"completion":1566,"start":1567,"enrollment":221,"conditions":1568,"interventions":1570},"NCT05484193","GnRH Agonist for Luteal Phase Support.",[80],"2022-04-15","2023-01-01","2020-06-08",[1569],"Use of GnRH Agonist Alone for Luteal Phase Support in Fresh IVF Cycles",[1547,1571],"Progesterone",{"nctId":1573,"briefTitle":1574,"status":325,"phases":1575,"primaryCompletion":1576,"completion":1576,"start":1577,"enrollment":1578,"conditions":1579,"interventions":1581},"NCT05838105","Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates",[80],"2025-01-01","2022-10-01",144,[1580],"Luteal Phase Support",[1547,1582,1583],"hCG","Progesterone 100Mg Vag Tab",{"intervention":1365,"totalTrials":299,"cells":1585},{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1596,"PHASE4":1598,"NA":1600},{"trials":1587,"activeCount":87},[],{"trials":1589,"activeCount":87},[],{"trials":1591,"activeCount":87},[1592],{"nctId":1359,"briefTitle":1360,"status":325,"phases":1593,"primaryCompletion":664,"start":1362,"enrollment":199,"conditions":1594,"interventions":1595},[77],[15],[1365,1350,1366],{"trials":1597,"activeCount":87},[],{"trials":1599,"activeCount":87},[],{"trials":1601,"activeCount":87},[1602],{"nctId":1603,"briefTitle":1604,"status":325,"phases":1605,"primaryCompletion":1606,"completion":1607,"start":395,"enrollment":806,"conditions":1608,"interventions":1610},"NCT01024348","Safety and Effectiveness of Tramadex-OD After Knee Arthroscopy",[80],"2010-12","2011-12",[1609],"Postoperative Pain",[1611,1612],"extended-release tramadol","paracetamol",{"intervention":1614,"totalTrials":83,"cells":1615},"Hexacapron",{"EARLY_PHASE1":1616,"PHASE1":1618,"PHASE2":1620,"PHASE3":1622,"PHASE4":1624,"NA":1626},{"trials":1617,"activeCount":87},[],{"trials":1619,"activeCount":87},[],{"trials":1621,"activeCount":87},[],{"trials":1623,"activeCount":87},[],{"trials":1625,"activeCount":87},[],{"trials":1627,"activeCount":87},[1628],{"nctId":1629,"briefTitle":1630,"status":325,"phases":1631,"primaryCompletion":1632,"completion":1632,"start":464,"enrollment":1633,"conditions":1634,"interventions":1639},"NCT02071316","The Use of Hexacapron in Upper Gastrointestinal Bleeding",[80],"2015-04",300,[1635,1614,1636,1637,1638],"Upper Gastrointestinal Bleeding","Hemostasis","Rebleeding","Mortality",[1614,1640],"esomeprazole",{"intervention":1640,"totalTrials":83,"cells":1642},{"EARLY_PHASE1":1643,"PHASE1":1645,"PHASE2":1647,"PHASE3":1649,"PHASE4":1651,"NA":1653},{"trials":1644,"activeCount":87},[],{"trials":1646,"activeCount":87},[],{"trials":1648,"activeCount":87},[],{"trials":1650,"activeCount":87},[],{"trials":1652,"activeCount":87},[],{"trials":1654,"activeCount":87},[1655],{"nctId":1629,"briefTitle":1630,"status":325,"phases":1656,"primaryCompletion":1632,"completion":1632,"start":464,"enrollment":1633,"conditions":1657,"interventions":1658},[80],[1635,1614,1636,1637,1638],[1614,1640],{"intervention":1571,"totalTrials":83,"cells":1660},{"EARLY_PHASE1":1661,"PHASE1":1663,"PHASE2":1665,"PHASE3":1667,"PHASE4":1669,"NA":1671},{"trials":1662,"activeCount":87},[],{"trials":1664,"activeCount":87},[],{"trials":1666,"activeCount":87},[],{"trials":1668,"activeCount":87},[],{"trials":1670,"activeCount":87},[],{"trials":1672,"activeCount":87},[1673],{"nctId":1562,"briefTitle":1563,"status":325,"phases":1674,"primaryCompletion":1565,"completion":1566,"start":1567,"enrollment":221,"conditions":1675,"interventions":1676},[80],[1569],[1547,1571],{"intervention":1678,"totalTrials":83,"cells":1679},"hepatitis B vaccine",{"EARLY_PHASE1":1680,"PHASE1":1682,"PHASE2":1684,"PHASE3":1686,"PHASE4":1688,"NA":1690},{"trials":1681,"activeCount":87},[],{"trials":1683,"activeCount":87},[],{"trials":1685,"activeCount":87},[],{"trials":1687,"activeCount":87},[],{"trials":1689,"activeCount":87},[],{"trials":1691,"activeCount":87},[1692],{"nctId":1693,"briefTitle":1694,"status":661,"phases":1695,"primaryCompletion":740,"completion":740,"start":1696,"enrollment":875,"conditions":1697,"interventions":1699},"NCT00739128","Response to Hepatitis B Vaccine in Celiac Disease Patients",[80],"2009-02",[1698],"Celiac Disease",[1678,1678],{"intervention":1582,"totalTrials":83,"cells":1701},{"EARLY_PHASE1":1702,"PHASE1":1704,"PHASE2":1706,"PHASE3":1708,"PHASE4":1710,"NA":1712},{"trials":1703,"activeCount":87},[],{"trials":1705,"activeCount":87},[],{"trials":1707,"activeCount":87},[],{"trials":1709,"activeCount":87},[],{"trials":1711,"activeCount":87},[],{"trials":1713,"activeCount":87},[1714],{"nctId":1573,"briefTitle":1574,"status":325,"phases":1715,"primaryCompletion":1576,"completion":1576,"start":1577,"enrollment":1578,"conditions":1716,"interventions":1717},[80],[1580],[1547,1582,1583],{"intervention":1583,"totalTrials":83,"cells":1719},{"EARLY_PHASE1":1720,"PHASE1":1722,"PHASE2":1724,"PHASE3":1726,"PHASE4":1728,"NA":1730},{"trials":1721,"activeCount":87},[],{"trials":1723,"activeCount":87},[],{"trials":1725,"activeCount":87},[],{"trials":1727,"activeCount":87},[],{"trials":1729,"activeCount":87},[],{"trials":1731,"activeCount":87},[1732],{"nctId":1573,"briefTitle":1574,"status":325,"phases":1733,"primaryCompletion":1576,"completion":1576,"start":1577,"enrollment":1578,"conditions":1734,"interventions":1735},[80],[1580],[1547,1582,1583],{"intervention":1737,"totalTrials":83,"cells":1738},"XALATAN®",{"EARLY_PHASE1":1739,"PHASE1":1741,"PHASE2":1743,"PHASE3":1745,"PHASE4":1747,"NA":1749},{"trials":1740,"activeCount":87},[],{"trials":1742,"activeCount":87},[],{"trials":1744,"activeCount":87},[],{"trials":1746,"activeCount":87},[],{"trials":1748,"activeCount":87},[],{"trials":1750,"activeCount":87},[1751],{"nctId":1752,"briefTitle":1753,"status":325,"phases":1754,"primaryCompletion":1755,"completion":917,"start":1756,"enrollment":383,"conditions":1757,"interventions":1761},"NCT03318146","Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP",[80],"2019-06-01","2018-06-01",[1758,1759,1760],"Glaucoma","Ocular Hypertension","IOP",[1737],{"intervention":1763,"totalTrials":83,"cells":1764},"tamoxifen",{"EARLY_PHASE1":1765,"PHASE1":1767,"PHASE2":1769,"PHASE3":1771,"PHASE4":1773,"NA":1775},{"trials":1766,"activeCount":87},[],{"trials":1768,"activeCount":87},[],{"trials":1770,"activeCount":87},[],{"trials":1772,"activeCount":87},[],{"trials":1774,"activeCount":87},[],{"trials":1776,"activeCount":87},[1777],{"nctId":1778,"briefTitle":1779,"status":325,"phases":1780,"start":1781,"enrollment":806,"conditions":1782,"interventions":1783},"NCT00449514","Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle",[80],"2007-05",[32],[1763,1784],"clomiphene citrate",{"intervention":1784,"totalTrials":83,"cells":1786},{"EARLY_PHASE1":1787,"PHASE1":1789,"PHASE2":1791,"PHASE3":1793,"PHASE4":1795,"NA":1797},{"trials":1788,"activeCount":87},[],{"trials":1790,"activeCount":87},[],{"trials":1792,"activeCount":87},[],{"trials":1794,"activeCount":87},[],{"trials":1796,"activeCount":87},[],{"trials":1798,"activeCount":87},[1799],{"nctId":1778,"briefTitle":1779,"status":325,"phases":1800,"start":1781,"enrollment":806,"conditions":1801,"interventions":1802},[80],[32],[1763,1784],{"intervention":1804,"totalTrials":83,"cells":1805},"BNT162b2",{"EARLY_PHASE1":1806,"PHASE1":1808,"PHASE2":1810,"PHASE3":1812,"PHASE4":1814,"NA":1816},{"trials":1807,"activeCount":87},[],{"trials":1809,"activeCount":87},[],{"trials":1811,"activeCount":87},[],{"trials":1813,"activeCount":87},[],{"trials":1815,"activeCount":87},[],{"trials":1817,"activeCount":87},[1818],{"nctId":1819,"briefTitle":1820,"status":314,"phases":1821,"primaryCompletion":1822,"completion":1823,"start":1824,"enrollment":1825,"conditions":1826,"interventions":1830},"NCT05308680","Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care Workers",[],"2022-01-24","2022-03-28","2022-01-06",336,[1827,1828,1829],"Myocardial Injury","Vaccine Adverse Reaction","COVID-19",[1804],{"intervention":1832,"totalTrials":83,"cells":1833},"Polymyxin E",{"EARLY_PHASE1":1834,"PHASE1":1836,"PHASE2":1838,"PHASE3":1840,"PHASE4":1842,"NA":1844},{"trials":1835,"activeCount":87},[],{"trials":1837,"activeCount":87},[],{"trials":1839,"activeCount":87},[],{"trials":1841,"activeCount":87},[],{"trials":1843,"activeCount":87},[],{"trials":1845,"activeCount":87},[1846],{"nctId":1847,"briefTitle":1848,"status":314,"phases":1849,"primaryCompletion":711,"completion":711,"start":395,"enrollment":782,"conditions":1850,"interventions":1852},"NCT01023087","Renal Impairment Associated With Colistin Levels",[],[1851],"Sepsis",[1832,1853],"Non-nephrotoxic antibiotics",{"intervention":1853,"totalTrials":83,"cells":1855},{"EARLY_PHASE1":1856,"PHASE1":1858,"PHASE2":1860,"PHASE3":1862,"PHASE4":1864,"NA":1866},{"trials":1857,"activeCount":87},[],{"trials":1859,"activeCount":87},[],{"trials":1861,"activeCount":87},[],{"trials":1863,"activeCount":87},[],{"trials":1865,"activeCount":87},[],{"trials":1867,"activeCount":87},[1868],{"nctId":1847,"briefTitle":1848,"status":314,"phases":1869,"primaryCompletion":711,"completion":711,"start":395,"enrollment":782,"conditions":1870,"interventions":1871},[],[1851],[1832,1853],{"intervention":1873,"totalTrials":83,"cells":1874},"Vedolizumab",{"EARLY_PHASE1":1875,"PHASE1":1877,"PHASE2":1879,"PHASE3":1881,"PHASE4":1883,"NA":1885},{"trials":1876,"activeCount":87},[],{"trials":1878,"activeCount":87},[],{"trials":1880,"activeCount":87},[],{"trials":1882,"activeCount":87},[],{"trials":1884,"activeCount":87},[],{"trials":1886,"activeCount":87},[1887],{"nctId":1888,"briefTitle":1889,"status":314,"phases":1890,"primaryCompletion":831,"completion":831,"start":1320,"enrollment":1891,"conditions":1892,"interventions":1895},"NCT02862132","Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases",[80],142,[24,1893,1894],"Ulcerative Colitis","Inflammatory Bowel Disease",[1873],{"intervention":1897,"totalTrials":83,"cells":1898},"n acetylcysteine",{"EARLY_PHASE1":1899,"PHASE1":1901,"PHASE2":1903,"PHASE3":1905,"PHASE4":1907,"NA":1909},{"trials":1900,"activeCount":87},[],{"trials":1902,"activeCount":87},[],{"trials":1904,"activeCount":87},[],{"trials":1906,"activeCount":87},[],{"trials":1908,"activeCount":87},[],{"trials":1910,"activeCount":87},[1911],{"nctId":1912,"briefTitle":1913,"status":314,"phases":1914,"primaryCompletion":1915,"completion":1429,"start":1247,"enrollment":329,"conditions":1916,"interventions":1918},"NCT00353340","Prevention of Contrast Nephropathy by Sodium Bicarbonate Versus Sodium Chloride and N-acetylcysteine",[80],"2008-01",[1917],"Acute Renal Failure Contrast Nephropathy",[1897,1919,1920],"sodium bicarbonate","sodium chloride",{"intervention":1919,"totalTrials":83,"cells":1922},{"EARLY_PHASE1":1923,"PHASE1":1925,"PHASE2":1927,"PHASE3":1929,"PHASE4":1931,"NA":1933},{"trials":1924,"activeCount":87},[],{"trials":1926,"activeCount":87},[],{"trials":1928,"activeCount":87},[],{"trials":1930,"activeCount":87},[],{"trials":1932,"activeCount":87},[],{"trials":1934,"activeCount":87},[1935],{"nctId":1912,"briefTitle":1913,"status":314,"phases":1936,"primaryCompletion":1915,"completion":1429,"start":1247,"enrollment":329,"conditions":1937,"interventions":1938},[80],[1917],[1897,1919,1920],{"intervention":1920,"totalTrials":83,"cells":1940},{"EARLY_PHASE1":1941,"PHASE1":1943,"PHASE2":1945,"PHASE3":1947,"PHASE4":1949,"NA":1951},{"trials":1942,"activeCount":87},[],{"trials":1944,"activeCount":87},[],{"trials":1946,"activeCount":87},[],{"trials":1948,"activeCount":87},[],{"trials":1950,"activeCount":87},[],{"trials":1952,"activeCount":87},[1953],{"nctId":1912,"briefTitle":1913,"status":314,"phases":1954,"primaryCompletion":1915,"completion":1429,"start":1247,"enrollment":329,"conditions":1955,"interventions":1956},[80],[1917],[1897,1919,1920],{"intervention":1958,"totalTrials":83,"cells":1959},"Callmax cream application over affected skin",{"EARLY_PHASE1":1960,"PHASE1":1962,"PHASE2":1964,"PHASE3":1966,"PHASE4":1968,"NA":1970},{"trials":1961,"activeCount":87},[],{"trials":1963,"activeCount":87},[],{"trials":1965,"activeCount":87},[],{"trials":1967,"activeCount":87},[],{"trials":1969,"activeCount":87},[],{"trials":1971,"activeCount":87},[1972],{"nctId":1973,"briefTitle":1974,"status":325,"phases":1975,"primaryCompletion":1976,"completion":1977,"start":1978,"enrollment":1979,"conditions":1980,"interventions":1982},"NCT02032537","Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus",[80],"2015-11","2016-05","2014-11",28,[1981],"Calmmax Cream on UP in CKD Patients.",[1958],{"intervention":1984,"totalTrials":83,"cells":1985},"Decapeptyl 0.1 mg after embryo transfer",{"EARLY_PHASE1":1986,"PHASE1":1988,"PHASE2":1990,"PHASE3":1992,"PHASE4":1994,"NA":1996},{"trials":1987,"activeCount":87},[],{"trials":1989,"activeCount":87},[],{"trials":1991,"activeCount":87},[],{"trials":1993,"activeCount":87},[],{"trials":1995,"activeCount":87},[],{"trials":1997,"activeCount":87},[1998],{"nctId":1999,"briefTitle":2000,"status":325,"phases":2001,"completion":2002,"start":730,"conditions":2003,"interventions":2005},"NCT00542126","Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles",[80],"2009-09",[2004],"Pregnancy Rate",[1984],{"intervention":2007,"totalTrials":83,"cells":2008},"AB",{"EARLY_PHASE1":2009,"PHASE1":2011,"PHASE2":2013,"PHASE3":2015,"PHASE4":2017,"NA":2019},{"trials":2010,"activeCount":87},[],{"trials":2012,"activeCount":87},[],{"trials":2014,"activeCount":87},[],{"trials":2016,"activeCount":87},[],{"trials":2018,"activeCount":87},[],{"trials":2020,"activeCount":87},[2021],{"nctId":2022,"briefTitle":2023,"status":314,"phases":2024,"primaryCompletion":1319,"completion":2025,"start":2026,"enrollment":1979,"conditions":2027,"interventions":2031},"NCT02033408","Manipulating the Microbiome in IBD by Antibiotics and FMT",[80],"2021-01","2014-01",[2028,2029,2030],"Exacerbation of Ulcerative Colitis","Ulcerative Colitis, Active Severe","Crohn's Colitis",[2007,2032],"CS (corticosteroids) Only",{"intervention":2032,"totalTrials":83,"cells":2034},{"EARLY_PHASE1":2035,"PHASE1":2037,"PHASE2":2039,"PHASE3":2041,"PHASE4":2043,"NA":2045},{"trials":2036,"activeCount":87},[],{"trials":2038,"activeCount":87},[],{"trials":2040,"activeCount":87},[],{"trials":2042,"activeCount":87},[],{"trials":2044,"activeCount":87},[],{"trials":2046,"activeCount":87},[2047],{"nctId":2022,"briefTitle":2023,"status":314,"phases":2048,"primaryCompletion":1319,"completion":2025,"start":2026,"enrollment":1979,"conditions":2049,"interventions":2050},[80],[2028,2029,2030],[2007,2032],{"intervention":2052,"totalTrials":83,"cells":2053},"Hepatitis B vaccination",{"EARLY_PHASE1":2054,"PHASE1":2056,"PHASE2":2058,"PHASE3":2060,"PHASE4":2062,"NA":2064},{"trials":2055,"activeCount":87},[],{"trials":2057,"activeCount":87},[],{"trials":2059,"activeCount":87},[],{"trials":2061,"activeCount":87},[],{"trials":2063,"activeCount":87},[],{"trials":2065,"activeCount":87},[2066],{"nctId":2067,"briefTitle":2068,"status":325,"phases":2069,"primaryCompletion":710,"completion":2070,"start":2071,"enrollment":875,"conditions":2072,"interventions":2073},"NCT01159457","Comparison of Engerix B Vaccine Versus Sci-B-Vac Vaccine in Celiac Patients",[80],"2013-01","2011-04",[1698],[2052,2052],{"intervention":1611,"totalTrials":83,"cells":2075},{"EARLY_PHASE1":2076,"PHASE1":2078,"PHASE2":2080,"PHASE3":2082,"PHASE4":2084,"NA":2086},{"trials":2077,"activeCount":87},[],{"trials":2079,"activeCount":87},[],{"trials":2081,"activeCount":87},[],{"trials":2083,"activeCount":87},[],{"trials":2085,"activeCount":87},[],{"trials":2087,"activeCount":87},[2088],{"nctId":1603,"briefTitle":1604,"status":325,"phases":2089,"primaryCompletion":1606,"completion":1607,"start":395,"enrollment":806,"conditions":2090,"interventions":2091},[80],[1609],[1611,1612],{"intervention":2093,"totalTrials":83,"cells":2094},"midazolam",{"EARLY_PHASE1":2095,"PHASE1":2097,"PHASE2":2099,"PHASE3":2101,"PHASE4":2103,"NA":2105},{"trials":2096,"activeCount":87},[],{"trials":2098,"activeCount":87},[],{"trials":2100,"activeCount":87},[],{"trials":2102,"activeCount":87},[],{"trials":2104,"activeCount":87},[],{"trials":2106,"activeCount":87},[2107],{"nctId":2108,"briefTitle":2109,"status":325,"phases":2110,"primaryCompletion":2002,"start":1498,"enrollment":199,"conditions":2111,"interventions":2113},"NCT00886314","Clown Doctors and a Sedative Premedicant for Children Undergoing Surgery",[80],[2112],"Insomnia",[2093],{"intervention":2115,"totalTrials":83,"cells":2116},"Elelyso",{"EARLY_PHASE1":2117,"PHASE1":2119,"PHASE2":2121,"PHASE3":2123,"PHASE4":2125,"NA":2127},{"trials":2118,"activeCount":87},[],{"trials":2120,"activeCount":87},[],{"trials":2122,"activeCount":87},[],{"trials":2124,"activeCount":87},[],{"trials":2126,"activeCount":87},[],{"trials":2128,"activeCount":87},[2129],{"nctId":2130,"briefTitle":2131,"status":314,"phases":2132,"primaryCompletion":2133,"completion":2133,"start":2134,"enrollment":2135,"conditions":2136,"interventions":2137},"NCT04353466","Assessing the Impact of Elelyso on Bone Involvement Currently Treated With Other ERTs",[80],"2021-07-31","2017-01-01",30,[28],[2115],{"intervention":2139,"totalTrials":83,"cells":2140},"GTA glyceryl triacetate",{"EARLY_PHASE1":2141,"PHASE1":2143,"PHASE2":2145,"PHASE3":2147,"PHASE4":2149,"NA":2151},{"trials":2142,"activeCount":87},[],{"trials":2144,"activeCount":87},[],{"trials":2146,"activeCount":87},[],{"trials":2148,"activeCount":87},[],{"trials":2150,"activeCount":87},[],{"trials":2152,"activeCount":87},[2153],{"nctId":2154,"briefTitle":2155,"status":325,"phases":2156,"primaryCompletion":722,"start":1216,"enrollment":83,"conditions":2157,"interventions":2159},"NCT00724802","Oral Glyceryl Triacetate (GTA) in Newborns With Canavan",[80],[2158],"Canavan Disease",[2139],{"intervention":2161,"totalTrials":83,"cells":2162},"Homeopathic Medication",{"EARLY_PHASE1":2163,"PHASE1":2165,"PHASE2":2167,"PHASE3":2169,"PHASE4":2171,"NA":2173},{"trials":2164,"activeCount":87},[],{"trials":2166,"activeCount":87},[],{"trials":2168,"activeCount":87},[],{"trials":2170,"activeCount":87},[],{"trials":2172,"activeCount":87},[],{"trials":2174,"activeCount":87},[2175],{"nctId":2176,"briefTitle":2177,"status":314,"phases":2178,"primaryCompletion":2179,"completion":2180,"start":2181,"enrollment":2182,"conditions":2183,"interventions":2185},"NCT03512639","Arnica Montana and Bellis Perennis for Prevention of Seroma After Mastectomy",[80],"2017-08-01","2018-04-01","2016-01-01",55,[2184],"Seroma",[2161],{"intervention":2187,"totalTrials":83,"cells":2188},"Opaganib",{"EARLY_PHASE1":2189,"PHASE1":2191,"PHASE2":2193,"PHASE3":2195,"PHASE4":2197,"NA":2199},{"trials":2190,"activeCount":87},[],{"trials":2192,"activeCount":87},[],{"trials":2194,"activeCount":87},[],{"trials":2196,"activeCount":87},[],{"trials":2198,"activeCount":87},[],{"trials":2200,"activeCount":87},[2201],{"nctId":2202,"briefTitle":2203,"status":314,"phases":2204,"primaryCompletion":2205,"completion":2206,"start":2207,"enrollment":2208,"conditions":2209,"interventions":2211},"NCT04435106","Compassionate Use of Opaganib in Patients With Coronavirus Disease 2019 (COVID-19)",[],"2020-05-01","2020-05-15","2020-04-03",23,[2210],"Coronavirus Infections",[2187,2212],"Standard of Care",{"intervention":2212,"totalTrials":83,"cells":2214},{"EARLY_PHASE1":2215,"PHASE1":2217,"PHASE2":2219,"PHASE3":2221,"PHASE4":2223,"NA":2225},{"trials":2216,"activeCount":87},[],{"trials":2218,"activeCount":87},[],{"trials":2220,"activeCount":87},[],{"trials":2222,"activeCount":87},[],{"trials":2224,"activeCount":87},[],{"trials":2226,"activeCount":87},[2227],{"nctId":2202,"briefTitle":2203,"status":314,"phases":2228,"primaryCompletion":2205,"completion":2206,"start":2207,"enrollment":2208,"conditions":2229,"interventions":2230},[],[2210],[2187,2212],{"intervention":2232,"totalTrials":83,"cells":2233},"Povidone-Iodine 1 % Topical Solution",{"EARLY_PHASE1":2234,"PHASE1":2236,"PHASE2":2238,"PHASE3":2240,"PHASE4":2242,"NA":2244},{"trials":2235,"activeCount":87},[],{"trials":2237,"activeCount":87},[],{"trials":2239,"activeCount":87},[],{"trials":2241,"activeCount":87},[],{"trials":2243,"activeCount":87},[],{"trials":2245,"activeCount":87},[2246],{"nctId":2247,"briefTitle":2248,"status":325,"phases":2249,"primaryCompletion":1270,"completion":1270,"start":2250,"enrollment":806,"conditions":2251,"interventions":2253},"NCT05160623","Treatment of Blepharitis With Povidone-Iodine 1%",[80],"2021-08-16",[2252],"Anterior Blepharitis",[2232,2254],"Eyelid cleansing wipes",{"intervention":2254,"totalTrials":83,"cells":2256},{"EARLY_PHASE1":2257,"PHASE1":2259,"PHASE2":2261,"PHASE3":2263,"PHASE4":2265,"NA":2267},{"trials":2258,"activeCount":87},[],{"trials":2260,"activeCount":87},[],{"trials":2262,"activeCount":87},[],{"trials":2264,"activeCount":87},[],{"trials":2266,"activeCount":87},[],{"trials":2268,"activeCount":87},[2269],{"nctId":2247,"briefTitle":2248,"status":325,"phases":2270,"primaryCompletion":1270,"completion":1270,"start":2250,"enrollment":806,"conditions":2271,"interventions":2272},[80],[2252],[2232,2254],{"intervention":2274,"totalTrials":83,"cells":2275},"Cerebrolysin",{"EARLY_PHASE1":2276,"PHASE1":2278,"PHASE2":2280,"PHASE3":2282,"PHASE4":2284,"NA":2286},{"trials":2277,"activeCount":87},[],{"trials":2279,"activeCount":87},[],{"trials":2281,"activeCount":87},[],{"trials":2283,"activeCount":87},[],{"trials":2285,"activeCount":87},[],{"trials":2287,"activeCount":87},[2288],{"nctId":2289,"briefTitle":2290,"status":325,"phases":2291,"primaryCompletion":2292,"completion":2293,"start":2294,"enrollment":2135,"conditions":2295,"interventions":2297},"NCT06070753","A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)",[80],"2024-06-30","2024-12-30","2023-10-01",[2296],"Acute Ischemic Stroke",[2274]]